Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
QuintilesIMS
Farmers Insurance
Medtronic
Cerilliant
Merck
Chubb
Chinese Patent Office

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,948,805

« Back to Dashboard

Summary for Patent: 4,948,805
Title: Salt of diclofenac with a pyrrolidine compound and pharmaceutical compositions which contain it
Abstract:The salt of diclofenac with a cyclic organic base is prepared by dissolving diclofenac in a suitable organic solvent, adding said cyclic organic base, reacting the two components together, removing the solvent and crystallizing the product obtained. Said salt is water soluble to an extent from 20% w/v to an extent exceeding 50% w/v, and is used to prepared pharmaceutical compositions preferably in granular form for use by dissolving in water for oral administration.
Inventor(s): Ziggiotti; Antonio (Vezia, CH), Di Schiena; Michele (Cisliano, IT)
Assignee: Altergon S. A. & Ricerfarma Srl. (IT)
Application Number:07/117,823
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 4,948,805

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,948,805

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Italy22320 A/86Nov 13, 1986

International Patents Family Members for US Patent 4,948,805

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 3769943 ➤ Try a Free Trial
Denmark 592987 ➤ Try a Free Trial
European Patent Office 0271709 ➤ Try a Free Trial
Spain 2029254 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Mallinckrodt
AstraZeneca
Medtronic
Teva
Daiichi Sankyo
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.